AMGN Summary

  1. NASDAQ
  2. >
  3. AMGN
TickerAMGN
DescriptionAMGEN INC
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
ExchangeNASDAQ
TypeStock
SectorHealthcare
Employees22,000
Next Earnings DateApril 27th, 2021
IV22.582823%
IV Percentile4th
IV Rank12.37%
IV Skew5.205798
IV Skew Percentile36th
IV Skew SentimentNeutral
Option Volume2,422
Volume1,368,801
Price$248.95
Previous Close$246.88
52-Week High$276.69
52-Week Low$207.34
50-Day Moving Avg.$238.28
200-Day Moving Avg.$233.94
10-Day Avg. Volume2,206,141
20-Day Avg. Volume2,995,331
30-Day Avg. Volume2,957,768
3-Month Avg. Volume2,697,619
PE20.15597
EPS$12.31
Outstanding Shares575,802,477
Market Capitalization$142,868,110,600
CurrencyUSD
UpdatedApril 10th, 2021